Advertisement

Citations to this article

Abstract

Despite striking advances in the biomedical sciences, the flow of new drugs has slowed to a trickle, impairing therapeutic advances as well as the commercial success of drug companies. Reduced productivity in the drug industry is caused mainly by corporate policies that discourage innovation. This is compounded by various consequences of mega-mergers, the obsession for blockbuster drugs, the shift of control of research from scientists to marketers, the need for fast sales growth, and the discontinuation of development compounds for nontechnical reasons. Lessons from the past indicate that these problems can be overcome, and herein, new and improved directions for drug discovery are suggested.

Authors

Pedro Cuatrecasas

×

Total citations by year

Year: 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 9 7 16 9 9 15 14 10 89
Citation information

Citations to this article in year 2009 (15)

Title and authors Publication Year
Advances in Nuclear Magnetic Resonance for Drug Discovery
R Powers
Expert Opinion on Drug Discovery 2009
The case for open-access chemical biology. A strategy for pre-competitive medicinal chemistry to promote drug discovery
J Weigelt
EMBO reports 2009
Inadequate dissemination of phase I trials: a retrospective cohort study
E Decullier, AW Chan, F Chapuis
PLoS Medicine 2009
Pharmacotherapy in Pediatric Critical Illness
C McDonnell, S Hum, H Frndova, CS Parshuram
Pediatric Drugs 2009
Nonprofit organizations and pharmaceutical research and development
WH Moos, JC Mirsalis
Drug Development Research 2009
Drug discovery: new models for industry–academic partnerships
CJ Tralau-Stewart, CA Wyatt, DE Kleyn, A Ayad
Drug Discovery Today 2009
Value networks identify innovation in 21st century pharmaceutical research
PJ Edwards
Drug Discovery Today 2009
Medicinal chemistry strategies in follow-on drug discovery
H Zhao, Z Guo
Drug Discovery Today 2009
Influence of molecular properties on oral bioavailability of lipophilic drugs – Mapping of bulkiness and different measures of polarity
MT Kuentz, Y Arnold
Pharmaceutical Development and Technology 2009
Pedro Cuatrecasas
Nature Reviews Drug Discovery 2009
The 'big pharma' dilemma: develop new drugs or promote existing ones?
D Weiss, P Naik, R Weiss
Nature Reviews Drug Discovery 2009
Orphan targets for reperfusion injury
J Inserte, JA Barrabes, V Hernando, D Garcia-Dorado
Cardiovascular Research 2009
Alcohol and Opioid Dependence Medications: Prescription Trends, Overall and by Physician Specialty
TL Mark, CA Kassed, R Vandivort-Warren, KR Levit, HR Kranzler
Drug and Alcohol Dependence 2009
Advances in Pharmacology
JM Witkin, X Li
Advances in Pharmacology 2009
The chemist as astronaut: Searching for biologically useful space in the chemical universe
DJ Triggle
Biochemical Pharmacology 2009

Advertisement
Advertisement